Transforming growth factor-β1 in the kidney and urine of patients with glomerular disease and proteinuria

Nephrology Dialysis Transplantation

Volumn 17, Issue 12, 2002, Pages 2145-2152

  Goumenos, Dimitrios S ^a   Tsakas, Sotiris ^a   El Nahas, Abdel Meguid ^b   Alexandri, Sotiria ^a   Oldroyd, Simon ^b   Kalliakmani, Pantelitsa ^a   Vlachojannis, John G ^a  

^a UNIVERSITY HOSPITAL OF PATRAS   (Greece)

^b NORTHERN GENERAL HOSPITAL   (United Kingdom)

Author keywords

Glomerular injury; Proteinuria; Transforming growth factor 1

Indexed keywords

CORTICOSTEROID DERIVATIVE; CYCLOSPORIN; CYCLOSPORIN A; MESSENGER RNA; PREDNISOLONE; TRANSFORMING GROWTH FACTOR BETA1;

ADULT; AGED; ARTICLE; CELL ACTIVATION; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOPLASM; ENZYME LINKED IMMUNOSORBENT ASSAY; EPITHELIUM CELL; FEMALE; GLOMERULOPATHY; HUMAN; IMMUNOGLOBULIN A NEPHROPATHY; IMMUNOHISTOCHEMISTRY; IMMUNOSUPPRESSIVE TREATMENT; IN SITU HYBRIDIZATION; KIDNEY BIOPSY; KIDNEY TUBULE CELL; MALE; MESANGIUM CELL; NEPHROTIC SYNDROME; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN SYNTHESIS; PROTEIN URINE LEVEL; PROTEINURIA; REMISSION; RNA SYNTHESIS; URINARY EXCRETION;

ADULT; AGED; CYCLOSPORINE; FEMALE; GLUCOCORTICOIDS; HUMANS; IMMUNOHISTOCHEMISTRY; IMMUNOSUPPRESSIVE AGENTS; IN SITU HYBRIDIZATION; KIDNEY DISEASES; KIDNEY GLOMERULUS; MALE; MIDDLE AGED; NEPHROTIC SYNDROME; OSMOLAR CONCENTRATION; PREDNISOLONE; PROTEINURIA; REMISSION INDUCTION; RNA, MESSENGER; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1;

EID: 0036899231     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/17.12.2145     Document Type: Article

References (23)

1. Roberts AB, Sporn MB. Physiological action and clinical applications of transforming growth factor-β. Growth Factors 1993; 8: 1-9
2. Border WA, Noble NA. Transforming growth factor-β in tissue fibrosis. N Engl J Med 1994; 9: 1286-1291
3. Lawrence AD. Transforming growth factor-β: an overview. Kidney Int 1995; 47 [Suppl 49]: S19-S23
4. Border WA, Ruoslahti E. Transforming growth factor-β in disease: the dark side of tissue repair. J Clin Invest 1992; 90: 1-7
5. Yamamoto T, Noble NA, Miller DA, Border WA. Sustained expression of TGF-β underlies development of progressive kidney fibrosis. Kidney Int 1994; 45: 916-927
6. 1 enhances glomerular collagen synthesis in diabetic rats. Diabetes 1993; 42: 1673-1677
7. 1. Nature 1990; 346: 371-374
8. Yamamoto T, Noble NA, Cohen AH et al. Expression of TGF-β in human glomerular disease. Kidney Int 1996; 49: 461-469
9. 1 and myofibroblasts: a potential pathway towards renal scarring in human glomerular disease. Nephron 2001; 87: 240-248
10. Jerums G, Panagiotopoulos S, Tsalamandris C, Allen T, Gilbert RE, Comper WD. Why is proteinuria such an important risk factor for progression in clinical trials? Kidney Int 1997; 52 [Suppl 63]: S87-S92
11. Remuzzi G. Nephropathic nature of proteinuria. Curr Op Nephrol Hypert 1999; 8: 655-663
12. Wang Y, Chen J, Chen L, Tay YC, Rangan GK, Harris DCH. Induction of monocyte chemoattractant protein-1 in proximal tubule cells by urinary protein. J Am Soc Nephrol 1997; 8: 1537-1545
13. Remuzzi G, Bertani T. Pathophysiology of progressive nephropathies. N Engl J Med 1998; 339: 1448-1456
14. Goumenos D, Brown CB, Shortland J, El Nahas AM. Myofibroblasts and the progression of mesangial IgA nephropathy. Nephrol Dial Transplant 1994; 9: 1418-1425
15. Williams MA, Lowrie JI. Fixation of tissues for morphometric study. In: Bach FL, Lock EA, eds. Nephrotoxicity in Experimental and Clinical Situations. Part I. Nijoff, Dordrecht: 1987: 141-166
16. 3, suggest different developmental functions in vivo. Development 1991; 111: 31-144
17. Virolainen P, Perala M, Yuorio E, Aro HT. Expression of matrix genes during incorporation of cancellous bone allografts and autografts. Clin Orthop Relat Res 1995; 317: 263-272
18. 1 in membranous glomerulonephritis. Nephrol Dial Transplant 1997; 12: 2562-2568
19. Khanna AK, Cairns VR, Becker CG, Hosenpud JD. TGF-beta. A link between immunosuppression, nephrotoxicity and cyclosporin. Transplant Proc 1998; 30: 944-945
20. El Nahas AM. Pathways to renal fibrosis. Exp Nephrol 1995; 3: 71-75
21. Desmouliere A, Geinoz A, Gabbiani F, Gabbiani G. TGF-β induces a smooth muscle actin expression in granulation tissue myofibroblasts and in quiescent cultured fibroblasts. J Cell Biol 1993; 122: 103-111
22. Shimizu A, Yamanaka N. Apoptosis and cell desquamation in repair process in ischemic tubular necrosis. Virchows Arch B Cell Pathol Incl Mol Pathol 1993; 64: 171-180
23. Fan JM, Ng YY, Hill PA et al. Transforming growth factor-P regulates tubular epithelial-myofibroblast transdifferentiation in vitro. Kidney Int 1999; 56: 1455-1467